smallpox

Documents about smallpox

• Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial#143629ClinicalTrials.gov
• Immune Responses to Smallpox Vaccination#905320ClinicalTrials.gov
• VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection#899190ClinicalTrials.gov
• Safety and Efficacy of CJ Smallpox Vaccine in Healthy Volunteers#152515ClinicalTrials.gov
• Haemorrhagic smallpox#649882WHO IRIS
• Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection#162542ClinicalTrials.gov
• A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects#208262ClinicalTrials.gov
• Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults#847377ClinicalTrials.gov
• A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects#146269ClinicalTrials.gov
• Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®#862348ClinicalTrials.gov
• A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects#174968ClinicalTrials.gov
• Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT#876148ClinicalTrials.gov
• Prospective Study for the FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at Risk#981860ClinicalTrials.gov
• Safety and Immunogenicity of CJ-50300#158048ClinicalTrials.gov
• Evaluation and Treatment of Eye Complications of Vaccinia Vaccination#824771ClinicalTrials.gov
• Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT#332817ClinicalTrials.gov
• Multifaceted contributions: health workers and smallpox eradication in India#346338White Rose Research Online
• ACAM2000® Myopericarditis Registry#843295ClinicalTrials.gov
• Phase I Trial of Smallpox Vaccine#249687ClinicalTrials.gov
• 42 U.S.C. § 239b — Smallpox vaccine injury table#595459US Code (LII)
• Combination Study With MVA BN and Dryvax#366645ClinicalTrials.gov
• Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects#835921ClinicalTrials.gov
• Phase I Trial of an Investigational Small Pox Medication#913108ClinicalTrials.gov
• Leprosy (_al-ǧuḏām_) and Smallpox (_al-ǧudarī_) in the _Kitāb al-Malakī_ and its Two Latin Translations#114724PhilArchive
• From Smallpox to Synthetic Biology: The Evolving Threat of Biological Weapons and the Jus Ad Bellum#226498Duke Law Scholarship Repository
• High Dose IMVAMUNE® in Vaccinia-Naive Individuals#966548ClinicalTrials.gov
• Code of the Mounted#65117Project Gutenberg
• MVA Post-Event: Administration Timing and Boost Study#851795ClinicalTrials.gov
• A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat#991822ClinicalTrials.gov
• Dick Kent with the Malemute Mail#55300Project Gutenberg
• Modeling epidemiological patterns of smallpox in Copenhagen in the 19th century after the introduction of the vaccine#379868bioRxiv / medRxiv
• VHA Clinicians and Bioterror Events: Interactive Web-based Learning#825260ClinicalTrials.gov
• Did smallpox reduce height?: stature and the standard of living in London, 1770-1873#167834LSE Research Online
• A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®#803658ClinicalTrials.gov
• Steppe productivity decline contributed to smallpox outbreak and the collapse of the last nomadic empire in the 1750s.#434119NCBI PubMed Central
• A comprehensive overview of monkeypox virus disease#784572Europe PMC
• Missed Opportunities: The Vaccine Act of 1813#485737Harvard DASH
• Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.#806182ClinicalTrials.gov
• Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years#272412ClinicalTrials.gov
• Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccination#284508IRIS
• An Open-Label Phase II Study to Evaluate Immunogenicity and Safety of a Single IMVAMUNE Booster Vaccination Two Years After the Last IMVAMUNE Vaccination in Former POX-MVA-005 Vaccinees#441960ClinicalTrials.gov
• EPIDEMIC, DISEASES PREVENTION, AND COLONIAL STATE: A BRIEF HISTORY OF EPIDEMIC DISEASES ACT (1897) IN COLONIAL INDIA#638714AGPE THE ROYAL GONDWANA RESEARCH JOURNAL OF HISTORY, SCIENCE, ECONOMIC, POLITICAL AND SOCIAL SCIENCE
• Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246#979327ClinicalTrials.gov
• Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections#136404ClinicalTrials.gov
• NOTIFICATIONS of plague, cholera, yellow fever, smallpox, typhus and relapsing fever under International Sanitary Legislation = NOTIFICATIONS de peste, choléra, fièvre jaune, variole, typhus et fièvre récurrente, aux termes de la législation sanitaire internationale#649913WHO IRIS
• A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age#918725ClinicalTrials.gov
• A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)#853572ClinicalTrials.gov
• The lively adventures of Gavin Hamilton#62335Project Gutenberg